UNSPSC 85814511: Introduction of other anti-infective into female reproductive, via natural or artificial opening endoscopic

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of other anti-infective into female reproductive, via natural or artificial opening endoscopic. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0P829

UNSPSC 85814511 Introduction of other anti-infective into female reproductive, via natural or artificial opening endoscopic, is a Commodity code that shows minimal alignment with actual state and local procurement activity in the recent opportunities block. The code's clinical specificity—targeting a narrow procedural intervention in reproductive medicine—does not match the diverse healthcare services state and local governments are currently soliciting.

Recent state and local contract opportunities posted under this code span virtual urgent care, occupational health and wellness services, cancer screening and registry services, behavioral health and opioid treatment programs, EMS revenue billing, nursing home operations, inmate medical services, employee health clinics, and medical director roles for fire departments and EMS systems. None of these solicitations involve anti-infective pharmaceutical introduction via endoscopic reproductive procedures. The code appears to have been applied to a series of broad healthcare procurement notices that fall well outside its nominal scope—Inland Empire Health Plan (California) requested virtual urgent care services (RFI, October 31, 2026 response); DeKalb County, Georgia sought general medical services (RFP, November 12, 2026); Nevada Health Authority requested Program of All Inclusive Care for the Elderly operations (RFP, December 10, 2026); and San Mateo County solicited cancer registry services and handheld retinal screening devices. The issuing bodies are predominantly county and regional health authorities, state health departments, and municipal health systems; activity concentrates in California, Georgia, Nevada, Colorado, and Florida, with scattered opportunities across Texas, Kansas, Arizona, and other states. The code shows little relevant recent activity and appears misapplied across these opportunities. Business development professionals should verify whether their service offering matches the clinical procedure this code nominally describes rather than assuming alignment with the posted opportunities listed under it.